Although some studies have shown that ascorbate has synergistic effects when combined with cisplatin or doxorubicin by increasing ROS levels and apoptotic activity in cervical cancer cells, the increased expression of wild-type p53 may also contribute to the synergistic effect through the p53 pathway [130,131]. This evidence concerns the gene TP53 and cervical cancer.